Standardized quantification of circulating peripheral tumor cells from lung and breast cancer

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 6, 2005, Pages 617-627

  Pachmann, Katharina ^a   Clement, Joachim H ^a   Schneider, Claus Peter ^b   Willen, Babette ^c   Camara, Oumar ^a   Pachmann, Ulrich ^c   Höffken, Klaus ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b ZENTRALKLINIK BAD BERKA   (Germany)

^c Tranfusionsmedizinisches Zentrum Bayreuth   (Germany)

Author keywords

Circulating tumor cells; Standardization; Therapy monitoring

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CELL COUNT; CELL FRACTIONATION; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; CYTOLYSIS; CYTOMETRY; EPITHELIUM CELL; ERYTHROCYTE; FLUOROCHROME STAINING; HUMAN; HUMAN CELL; LEUKOCYTE; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SOLID TUMOR; SUCROSE DENSITY GRADIENT CENTRIFUGATION; TUMOR CELL LINE; BLOOD SAMPLING; BREAST TUMOR; FEMALE; FLOW CYTOMETRY; IMMUNOMAGNETIC SEPARATION; LONGITUDINAL STUDY; LUNG TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; STANDARD; TUMOR EMBOLISM; TUMOR VOLUME; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; BLOOD SPECIMEN COLLECTION; BREAST NEOPLASMS; CELL COUNT; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOMAGNETIC SEPARATION; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; TUMOR BURDEN;

EID: 26044436866     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2005.107     Document Type: Article

References (41)

1. -7. Proc Natl Acad Sci USA 1995; 92:537-41.
2. Riethmueller G, Schlimok G, Kufer P, Gruber R, Holz E, Pantel K. Minimal residual disease in solid cancer: the diagnostic and therapeutic opportunity for monoclonal antibodies. Ann Oncol 1996;7(Suppl 1):17.
3. Ghossein RA, Rossai J. Polymerase chain reaction in the detection of micrometastases and circulating tumour cells. Cancer 1996;78:10-6.
4. Ross AA. Minimal residual disease in solid tumour malignancies: a review. J Hematother 1998;7:9-18.
5. Pantel K, von Knebel Doeberitz M, Izbicki JR, Riethmüller G. Disseminierte Tumorzellen: Diagnostik, prognostische Relevanz, Phänotypisierung und therapeutische Strategien. Chirurg 1997;68:1241-50.
6. Bessa X, Elizalde JI, Boix L, Pinol V, Lacy AM, Salo J, et al. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology 2001;120:1084-92.
7. r 34,000 is a widely distributed human carcinoma marker. Br J Cancer 1987;56:714-21.
8. Pachmann K, Heiß P, Demel U, Tilz G. Detection and quantification of small numbers of circulating tumor cells in peripheral blood using Laser Scanning Cytometry (LSC®). Clin Chem Lab Med 2001;39:811-7.
9. Schlimok G, Funke I, Pantel K, Strobel F, Lindemann F, Witte J, et al. Micrometastatic tumor cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 1991;27:1461-5.
10. Thorban S, Rosenberg R, Busch R, Roeder RJ. Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis. Br J Cancer 2000;83:35-9.
11. Sabile A, Louha M, Bonte E, Poussin K, Vona G, Mejean A, et al. Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection. Am J Clin Pathol 1999;112:171-8.
12. Braun S, Pantel K, Müller P, Janni W, Hepp F, Kentenich C, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer. N Engl J Med 2000;342:526-33.
13. Liotta LA, Kleinermann J, Sidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 1974;34:997-1004.
14. Baran J, Pituch-Noworolska A, Krzezowiak A, Wieckiewicz J, Stachura J, Pryjma J, et al. Detection of cancer cells in the blood by FACS sorting of CD45 cells. Int J Mol Med 1998;1:573-8.
15. Pantel K, Felber E, Schlimok G. Detection and characterization of residual disease in breast cancer. J Hematother 1994;3:315-22.
16. Diel IJ, Kaufmann M, Costa SD, Holle R, von Minckwitz G, Solomayer EF, et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 1996;88:1652-8.
17. Lilleng PK, Harveit F. Missed micrometastases - the extent of the problem. Acta Oncol 2000;39:313-7.
18. Nakamura T, Yasamura T, Hayashi K, Educhi R, Ide H, Takasaki K, et al. Immunocytochemical detection of circulating esophageal carcinoma cells by immunomagnetic separation. Anticancer Res 2000;20:4739-44.
19. Weitz J, Kienle P, Magener A, Koch M, Schrodel A, Willeke F, et al. Detection of disseminated colorectal cancer cells in lymph nodes blood and bone marrow. Clin Cancer Res 1999;5:1830-6.
20. Lopez-Guerrero JA, Gilabert PB, Gonzalez EB, Sanz Alonso MA, Perez JP, Talens AS, et al. Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19 and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistry. J Hematother 1999;8:53-61.
21. Jung R, Petersen K, Krueger W, Wolf M, Wagener C, Zander A, et al. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Br J Cancer 1999;81:870-3.
22. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW, et al. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 1998;95:4589-9.
23. Fodstad O, Faye R, Hoifodt HK, Skovlund E, Aamdal S. Immunobead based detection and characterization of circulating tumor cells in melanoma patients. Recent Results Cancer Res 2001;158:40-50.
24. Bilkenroth U, Taubert H, Riemann D, Rebmann U, Heynemann H, Meye A. Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation. Int J Cancer 2001; 92:577-82.
25. Hermanek P, Hutter RV, Sobin LH, Wittekind C. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 1999;86: 2668-73.
26. des Guetz G, Lacortes JM, Camilleri-Broet S, Bouillot JL, de Mestier P. Micrometastases in colonic cancers: diagnostic methods and prognostic elements. J Chir 2002; 139:141-8.
27. von Knebel-Doeberitz M, Koch M, Weitz J, Herfarth C. Diagnosis and significance of minimal residual disease in patients with colorectal carcinoma. Zentralbl Chir 2000;125(Suppl 1):15-9.
28. Jiao X, Krasna MJ. Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology. Ann Thorac Surg 2002;74:278-84.
29. Tsavellas G, Patel H, Allen-Mersh TG. Detection and significance of occult tumor cells in colorectal cancer. Br J Surg 2001;88:1307-20.
30. Iorgulescu DG, Kiroff GK. Minimal residual marrow disease: detection and significance of isolated tumour cells in bone marrow. ANZ J Surg 2001;71:365-76.
31. Martin VM, Siewert C, Scharl A, Harms T, Heinze R, Öhl S, et al. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp Hematol 1998;26:252-64.
32. Krag DN, Ashikaga T, Moss TJ, Kusminsky RE, Feldman S, Carp NZ, et al. Breast cancer cells in the blood: a pilot study. Breast J 1999;5:354-58.
33. Iinuma H, Okinaga K, Adachi M, Suda K, Sekine T, Sakagawa K, et al. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and k-ras gene in patients with colorectal cancer. Int J Cancer 2000;89:337-44.
34. Siewert C, Herber M, Hunzelmann N, Fodstad O, Miltenyi S, Assenmacher M, et al. Rapid enrichment and detection of melanoma cells from peripheral blood mononuclear cells by a new assay combining immunomagnetic cell sorting and immunocytochemical staining. Recent Results Cancer Res 2001;158:51-60.
35. Zigeuner RE, Riesenberg R, Pohla H, Hofstetter A, Oberneder R. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro. J Urol 2003; 169:701-5.
36. Tsavellas G, Huang A, McCullough T, Patel H, Araia R, Allen-Mersh TG. Flow cytometry correlates with RT-PCR for detection of spiked but not circulating colorectal cancer cells. Clin Exp Metastasis 2002;19:495-502.
37. Bertau P, Dumas F, Gala J-L, Eschwege P, Laour B, Philippe M, et al. Molecular detection of circulating prostate cells in cancer II: comparison of prostate epithelial cell isolation procedures. Clin Chem 1998;44:1750-3.
38. Benez A, Geiselhart A, Handgretinger R, Schiebel U, Fierlbeck G. Detection of circulating melanoma cells by immunomagnetic cell sorting. J Clin Lab Anal 1999; 13:229-33.
39. Gertler R, Rosenberg R, Fuehrer K, Dahm M, Nekarda H, Siewert JR. Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. Recent Results Cancer Res 2003;162:149-55.
40. Vlems FA, Ladanyi A, Gertler R, Rosenberg R, Diepstra JH, Roder C, et al. Reliability of quantitative reverse-transcriptase-PCR-based detection of tumour cells in the blood between different laboratories using a standardised protocol. Eur J Cancer 2003;39:388-96.
41. Schamhart D, Swinnen J, Kurth KH, Westerhof A, Kusters R, Borchers H, et al. Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin as evaluated for prostate cancer cells. Clin Chem 2003; 49:1458-66.